X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6) 6
index medicus (6) 6
female (5) 5
male (5) 5
middle aged (5) 5
multiple myeloma (5) 5
adult (4) 4
aged (4) 4
multiple myeloma - therapy (4) 4
transplantation, autologous (4) 4
autologous transplantation (3) 3
combined modality therapy (3) 3
hematology (3) 3
hematology, oncology and palliative medicine (3) 3
hematopoietic stem cell transplantation - methods (3) 3
treatment outcome (3) 3
200 mg/m melphalan (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
biotechnology & applied microbiology (2) 2
bone-marrow-transplantation (2) 2
care and treatment (2) 2
chemotherapy (2) 2
follow-up studies (2) 2
high-dose melphalan (2) 2
kaplan-meier estimate (2) 2
medicine, research & experimental (2) 2
melphalan - adverse effects (2) 2
melphalan - therapeutic use (2) 2
multiple myeloma - drug therapy (2) 2
oncology (2) 2
prospective studies (2) 2
remission induction (2) 2
stem-cell transplantation (2) 2
adults (1) 1
advanced basic science (1) 1
analysis (1) 1
antibodies (1) 1
antigens, cd34 - metabolism (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
asct (1) 1
autologous stem cell transplantation (1) 1
biosimilar g-csf (1) 1
biosimilar pharmaceuticals - pharmacology (1) 1
bone marrow transplantation - methods (1) 1
boronic acids - administration & dosage (1) 1
boronic acids - adverse effects (1) 1
bortezomib (1) 1
care (1) 1
cell & tissue engineering (1) 1
cell biology (1) 1
children (1) 1
collection (1) 1
conditioning regimen (1) 1
cost (1) 1
development and progression (1) 1
dexamethasone (1) 1
dexamethasone - administration & dosage (1) 1
disease-free survival (1) 1
doxorubicin - administration & dosage (1) 1
elderly-patients (1) 1
engraftment (1) 1
experience (1) 1
fatigue (1) 1
fatigue - etiology (1) 1
febrile neutropenia - etiology (1) 1
filgrastim (1) 1
filgrastim - pharmacology (1) 1
g-csf (1) 1
genetic aspects (1) 1
granulocyte colony-stimulating factor - pharmacology (1) 1
health aspects (1) 1
helical tomotherapy (1) 1
hematology, oncology, and palliative medicine (1) 1
hematopoietic stem cell mobilization - methods (1) 1
hematopoietic stem cells - metabolism (1) 1
high-dose therapy (1) 1
home care services (1) 1
hospital-care (1) 1
induction chemotherapy (1) 1
induction treatment prior (1) 1
intergroupe francophone (1) 1
intravenous melphalan (1) 1
lenalidomide (1) 1
lenalidomide maintenance (1) 1
leukemia (1) 1
long-term results (1) 1
maintenance chemotherapy (1) 1
malignancies (1) 1
melphalan - administration & dosage (1) 1
mental health (1) 1
metaanalysis (1) 1
multiple myeloma - mortality (1) 1
multiple myeloma - surgery (1) 1
neutropenia - chemically induced (1) 1
neutrophil recovery (1) 1
new drugs (1) 1
newly-diagnosed myeloma (1) 1
non-randomized controlled trials as topic (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 03/2014, Volume 32, Issue 7, pp. 634 - 640
Journal Article
Expert Opinion on Orphan Drugs, ISSN 2167-8707, 11/2017, Volume 5, Issue 11, pp. 875 - 887
Introduction: High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT) has long been established as the standard of care for eligible patients... 
multiple myeloma | conditioning regimen | ASCT | high-dose melphalan | PLUS MELPHALAN | PREPARATIVE REGIMEN | BONE-MARROW-TRANSPLANTATION | INTERGROUPE FRANCOPHONE | INTRAVENOUS MELPHALAN | 200 MG/M MELPHALAN | PHARMACOLOGY & PHARMACY | HELICAL TOMOTHERAPY | PROTEASOME INHIBITORS | LENALIDOMIDE MAINTENANCE
Journal Article
Cytotherapy, ISSN 1465-3249, 2015, Volume 17, Issue 10, pp. 1485 - 1493
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.